Your browser doesn't support javascript.
loading
Lipoxygenase inhibitor ML351 dysregulated an innate inflammatory response leading to impaired cardiac repair in acute heart failure.
Tourki, Bochra; Black, Laurence M; Kain, Vasundhara; Halade, Ganesh V.
Affiliation
  • Tourki B; Division of Cardiovascular Sciences, Department of Medicine, The University of South Florida, Tampa, FL, United States.
  • Black LM; Division of Nephrology, Department of Medicine, The University of Alabama at Birmingham, AL, United States.
  • Kain V; Division of Cardiovascular Sciences, Department of Medicine, The University of South Florida, Tampa, FL, United States.
  • Halade GV; Division of Cardiovascular Sciences, Department of Medicine, The University of South Florida, Tampa, FL, United States. Electronic address: ghalade@usf.edu.
Biomed Pharmacother ; 139: 111574, 2021 Jul.
Article in En | MEDLINE | ID: mdl-33862495
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Inflammatory Agents, Non-Steroidal / Lipoxygenase Inhibitors / Heart Failure / Isoxazoles / Naphthalenes Limits: Animals Language: En Journal: Biomed Pharmacother Year: 2021 Document type: Article Affiliation country: United States Country of publication: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Inflammatory Agents, Non-Steroidal / Lipoxygenase Inhibitors / Heart Failure / Isoxazoles / Naphthalenes Limits: Animals Language: En Journal: Biomed Pharmacother Year: 2021 Document type: Article Affiliation country: United States Country of publication: France